Toxic nephropathy: Adverse renal effects caused by drugs.
Unwin RJ.
Eur J Intern Med. 2022 Feb;96:20-25. doi: 10.1016/j.ejim.2021.09.008. Epub 2021 Oct 1.
Advances in the pathogenesis and prevention of contrast-induced nephropathy.
Zhang F, Lu Z, Wang F.
Life Sci. 2020 Oct 15;259:118379. doi: 10.1016/j.lfs.2020.118379. Epub 2020 Sep 3.
Toxic nephropathy: environmental chemicals.
Van Vleet TR, Schnellmann RG.
Semin Nephrol. 2003 Sep;23(5):500-8. doi: 10.1016/s0270-9295(03)00094-9.
Toxic nephropathy due to drugs, solvents and metals.
Schreiner GE.
Prog Biochem Pharmacol. 1972;7:248-84.
Toxic nephropathy from diagnostic and therapeutic agents. Review and commentary.
Roxe DM.
Am J Med. 1980 Nov;69(5):759-66. doi: 10.1016/0002-9343(80)90446-5.
Mesoamerican Nephropathy.
Correa-Rotter R, García-Trabanino R.
Semin Nephrol. 2019 May;39(3):263-271. doi: 10.1016/j.semnephrol.2019.02.004.
Common mechanisms in nephropathy induced by toxic metals.
Sabolić I.
Nephron Physiol. 2006;104(3):p107-14. doi: 10.1159/000095539. Epub 2006 Aug 29.
Aristolochic acid nephropathy.
Gökmen MR, Lord GM.
BMJ. 2012 Jun 15;344:e4000. doi: 10.1136/bmj.e4000.
[Toxic nephropathy].
Shibasaki T.
Ryoikibetsu Shokogun Shirizu. 1997;(16 Pt 1):567-70.
[Prevention of contrast-induced nephropathy].
Cousin F, Moïse M, Ilbert C, Meunier P, Jouret F.
Rev Med Liege. 2024 Jun;79(5-6):418-423.
